Millions of Americans could be affected by "work-for-Medicaid" ruling

A federal court hearing has been scheduled for Friday regarding the Trump administration’s decision to give states the power to enforce work requirements on Medicaid enrollees. 

The lawsuit was originally meant to determine whether thousands of low-income adults in Kentucky would have to work or volunteer to retain  healthcare coverage, but the ruling could affect millions of Medicaid enrollees nationwide.

At present, only four states—Kentucky, Indiana, Arkansas and New Hampshire have federal backing to mandate work for Medicaid enrollees. Additional states are slated to join.

To read the story, click the link below:

""

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.